40
Participants
Start Date
March 21, 2024
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2027
Glofitamab + Obinutuzumab
Duration of each cycle is 21 days. Cycle 1: R-CHOP Cycle 2: G-CHOP + glofitamab (at this cycle onnly, Obinutuzumab will be injected instead of Rituximab in order to decreased the risk of cytokine released syndrome) Cycle 3-6: R-CHOP + glofitamab Cycle 7-8: glofitamab alone
RECRUITING
Toulouse - IUCT Oncopole - Service d'Hématologie, Toulouse
NOT_YET_RECRUITING
Bordeaux Pessac, Pessac
NOT_YET_RECRUITING
MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique, Montpellier
NOT_YET_RECRUITING
RENNES - CHU Pontchaillou - Hématologie Clinique, Rennes
NOT_YET_RECRUITING
TOURS - Hôpital Bretonneau, Tours
NOT_YET_RECRUITING
Grenoble - CHUGA - Hématologie Clinique, Grenoble
NOT_YET_RECRUITING
Angers Chu, Angers
NOT_YET_RECRUITING
Reims Chu, Reims
NOT_YET_RECRUITING
NANCY - CHU Brabois, Vandœuvre-lès-Nancy
NOT_YET_RECRUITING
LILLE GHICL - Hôpital Saint Vincent de Paul, Lille
NOT_YET_RECRUITING
LILLE CHU - Hôpital Claude Huriez, Lille
NOT_YET_RECRUITING
Clermont-Ferrand - Chu Estaing, Clermont-Ferrand
NOT_YET_RECRUITING
BAYONNE - CH de la Côte Basque - Hématologie, Bayonne
NOT_YET_RECRUITING
Strasbourg - Icans, Strasbourg
NOT_YET_RECRUITING
LYON-Centre Léon Bérard, Lyon
RECRUITING
LYON HCL - CH Lyon Sud, Pierre-Bénite
NOT_YET_RECRUITING
APHP - Hôpital Saint-Louis - Hématologie adultes, Paris
NOT_YET_RECRUITING
APHP - Hôpital Saint-Antoine - Hématologie et thérapie cellulaire, Paris
NOT_YET_RECRUITING
APHP - Hôpital Pitié Salpêtrière - Hématologie, Paris
NOT_YET_RECRUITING
ROUEN - Centre Henri Becquerel - Service Hématologie Clinique, Rouen
NOT_YET_RECRUITING
Amiens-Picardie Chu, Amiens
NOT_YET_RECRUITING
LIMOGES - CHU Dupuytren 1, Limoges
Hoffmann-La Roche
INDUSTRY
French Innovative Leukemia Organisation
OTHER